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Abstract 
Cyclophilin-B (bCyP-20) was isolated in a relatively high quantity from calf brain and spleen tissues consecutively applying weak cation exchange, 
chromatofocusing and strong cation exchange chromatographies. Edman degradation yielded the N-terminal sequence NH2-DEKKKGPKVTVK- 
VYFDLRIGDEDIGRVVIGLFGKTVPKTVDNFVAL. Bovine cyclophilin-B possesses the peptidylproline cis-trans isomerase ctivity which is 
inhibited by nM concentrations of CsA. bCyP-20 has a strong tendency to bind to cation exchangers including DNA and heparin. It could be released 
from DNA affinity column at concentrations of NaCI higher than 200 mM. Circular dichroism spectroscopy revealed that bovine cyclophilin-A 
(bCyP-18) and bCyP-20 in aqueous olution have similar conformations. 
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1. Introduction 
The mammalian group of cyclophilins consists of at 
least eight different proteins which show high sequence 
similarity of their peptidylproline cis-trans isomerase 
(PPIase) domains [1]. The PPIase activity of the majority 
of cyclophilins can be inhibited by nanomolar concentra- 
tion of the clinically useful immunosuppressant cy-
closporin-A (CsA) [1]. The apo forms of hCyP-18 and 
hCyP-20 bind to various proteins i cluding the Gag pro- 
tein of the HIV class II virus [2] whereas their complexes 
with CsA bind and inhibit the phosphatase activity of 
calcineurin [3-4]. The latter effect is believed to be a 
crucial step which effectively blocks early T-cell activa- 
tion cascade and constitutes the base of the immunosup- 
pressive activity of CsA and its derivatives [5]. CyP-18 
was localized in the cytosol [6] in contrast o CyP-20 
which was found in the endoplasmic reticulum associ- 
ated with the highly acidic calcium-storage protein cal- 
reticulin [7]. The calmodulin-dependent phosphatase cal- 
cineurin which binds to CyP-18/CsA and CyP-20/CsA 
complexes with high affinities occurs both in the cytosol 
and membrane fraction [8]. It is thus possible that the 
CyP-18/CsA complex inhibits in vivo the activity of the 
cytosolic fraction of calcineurin which in turn pro- 
hibits translocation of the cytosolic form of nuclear fac- 
tor of activated T-cells (NFATc) to the nucleus [5]. The 
*Corresponding author. Fax: (33) (1) 6908 9137. 
The N-terminal sequence of bCyP-20 has been deposited to the EMBL 
Sequence Data Bank with the following accession number 
EMBL:P80311. The prefixes (h,b,m) in front of cyclophilin (CyP) cor- 
respond to: h, human; b, bovine; m, murine; the numbers correspond 
to approximate molecular mass (kDa) of the protein. 
membrane-associated fraction of calcineurin may thus 
bind in vivo the CyP-20/CsA complex which in turn may 
affect other cellular processes and lead to suppression/ 
toxicity of various lymphoid and non-lymphoid cells. 
In this communication we show that cyclophilin-B is 
an abundant protein in bovine brain tissues and that in 
aqueous olution it has a conformation similar to that of 
bCyP-18 and hCyP-18. This latter finding may explain 
strong in vitro inhibiton of the phosphatase activity of 
calcineurin by the CyP-20/CsA or CyP-18/CsA com- 
plexes [3,4] and may imply that both proteins have other 
common intracellular targets. 
Materials and methods 
2.1. Tissue sources, chemicals, chromatography materials and gel 
electrophoresis 
Calf brain and spleen were supplied fresh on ice by the Henri Meunier 
slaughter house (Meaux, 77, France). The fresh tissue was shredded and 
frozen in liquid nitrogen. Acrylamide, N,N'-methylenebisacrylamide, 
ammonium persulfate, N,N,N',N'-tetramethyle nediamine were pur- 
chased from Serva. Pharmalyte 8-10.5 and Ampholite 9-11 were from 
Pharmacia/LKB. Molecular mass markers were purchased from Bio- 
Rad. PBE 118 and CM-sepharose were from Pharmacia/LKB. All other 
chemicals were analytical grade and purchased from either Serva or 
Sigma. SDS-PAGE, 2D (NEPHGE/SDS-PAGE) gels (12%, size 
20 × 20 cm) and binding of bCyP-20 or bCyP-18 to calf thymus DNA 
and heparin affinity gels (Sigma) were performed according to the 
procedures described previously [9]. The peptidylproline cis-trans isom- 
erase (PPIase) assay was performed at 10*C using the succinyl-Ala-Ala- 
Pro-Phe-p-nitroanilide tetrapeptide as a substrate [10]. 
2.2. Preparation ftissue samples and primary processing of oluble 
proteins 
Frozen brain tissues were dry-homogenized with a Waring blender 
and dispersed in buffer containing 0.250 M NaCI, 10% glycerol, 50 mM 
phosphate, pH 7.2, 5 mMfl-ME, 0.5% Triton X-100, 0.02% NaN3 and 
1 mM PMSF. The mixture was cleared from insoluble debris by centrif- 
ugation and the resulting supernatant was dialyzed against 50 mM 
phosphate buffer (pH 7.2) containing 10% (v/v) of ethanol, 2mMfl-ME 
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Fig. 1. SDS-PAGE analyses of the elution profiles of bCyP-20 from CM-sepharose and PBEII8. (A) Aliquots of 9 different fractions from a 
CM-sepharose column were fractionated on a 12% SDS-PAGE and visualized by silver staining: lane 1, molecular mass markers; lanes 2-10, proteins 
which were eluted with increasing concentration f NaCI from 0.05 M to 1.0 M. 03) Aliquots from a PBE118 chromatofocusing column were resolved 
on a 12% SDS-PAGE gel: lane 1, molecular mass markers; lanes 2-14, proteins in fractions whose pHs decrease from 10.5 to 8.5; the majority of 
bCyP-20 was found in fractions 7 and 8. 
and 1 mM PMSF. Proteins were loaded onto a CM-separose column 
(5 cmx 40 ore) and eluted with increasing concentration of NaCI in 
phosphate buffer. 
2.3. Fractionation fbasic proteins and final purification of bCyP-20 
The mixture of proteins enriched with bCyP-20 was concentrated, 
followed by extensive dialyzis against 0.025 M triethylamine. HC1, 
pH 11 (PBEll8 buffer). The dialized mixture of proteins was appfied 
onto a PBE118 column (1.6 cmx 20 cm) which was equilibrated with 
100 void volumes of the PBE118 buffer. Proteins were eluted with the 
Ampholite 8--10.5 (1:45 v/v in water, pH 8.0). The fractions (8 ml each) 
were collected at a speed of about 80 ml per hour. The pH of each 
fraction was measured with a pH electrode. The fractions containing 
bCyP-20 were dialized against 25 mM phosphate buffer and applied 
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directly onto a MonoS (Pharmacia) column equilibrated with 25 mM 
phosphate, pH 7.2. bCyP-20 was eluted in a gradient of salt from 25 
mM to 1 M NaCI. 
2.4. Sequencing of proteins and computer analyses of protein sequences 
The N-terminal sequences ofbCyP-20 and bCyP-18 were established 
by Edman degradation using an Applied Biosystems Model 477A pro- 
tein sequencer. Amino acid compositions were established with an 
Applied Biosystem 420A derivatizer, msd is the root-mean-square- 
difference of amino acid compositions of proteins A and B calculated 
according to equation (1) for n = 16 (see Table 1), 
n 
rmsd = {lln ~ [P~a(%) - PB i (~) ]  2} 1/2 (1) 
where PA and Pe are the percentages ofeach amino acid in proteins A
and B. The sequences of cyclophilins were extracted from the MIPSX, 
PIR and EMBL protein data-banks (tel. 36, 37 and 28, containing 
73,891, 56,849 and 36,000 protein sequences, respectively) using the 
SEQPRO program [10]. Total hydrophobicity index (H.O was previ- 
ously defined [1]. 
2.5. Circular dichroism spectroscopy 
Circular dichroism spectra (CD) were recorded with a Jobin-Yvon 
Mark VI diehrograph. The spectra were measured with quartz squared 
cuvettes at room temperature in 20 mM phosphate, pH 7.3. Data were 
averaged over 10 repetitive scans. Protein concentrations were esti- 
mated by means of molar extinction coefficients at 2 278 nm, e = 8,400 
and e = 15,000 M -~ - cm -t for bCyP-18 and bCyP-20, respectively. The 
mean molecular ellipticity 0 was calculated using a mean residual mass 
of 111 and expressed in deg • cm 2 • dmol -~ units. 
3. Results and discussion 
Cyclophilin-B was isolated from bovine brain tissues 
using the following three consecutive steps: (i) trapping 
of proteins on a weak cation exchanger; (ii) sorting of 
proteins according to their pIs on a PB 118 chromatofo- 
cusing column; (iii) final purification on a strong cation 
exchanger (see Fig. 1A,B). From 1 kg of dry brain matter 
we purified nearly 5 mg of bCyP-20. Only one isoform 
of bCyP-20 with pI ca. 9.8 (see Fig. 2A) was found in calf 
brain tissues. On a 12% SDS-PAGE gel bCyP-20 nil- 
Table 1 
Amino acid compositions of hCyP-20, bCyP-20 and bCyP-18 
No Amino acid* hCyP-20 bCyP-20 bCyP- 18 
1 Ala 4.4 (8) 5.7 (10) 5.7 (9) 
2 Asx 11.1 (20) 10.8 (20) 10.7 (17) 
3 Arg 3.9 (7) 3.7 (7) 3.8 (6) 
4 Glx 7.2 (13) 7.7 (14) 8.2 (13) 
5 Gly 12.8 (23) 12.7 (23) 14.6 (24) 
6 His 1.7 (3) 1.4 (3) 2.5 (4) 
7 Ile 5.6 (10) 5.5 (10) 7.0 (11) 
8 Leu 3.9 (7) 5.0 (9) 3.8 (6) 
9 Lys 13.9 (25) 12.7 (23) 8.7 (14) 
10 Met 1.7 O) 1.4 (3) 2.5 (4) 
11 Phe 7.8 (14) 7.9 (14) 9.5 (15) 
12 Pro 3.3 (6) 4.2 (8) 3.8 (6) 
13 Ser 3.3 (6) 2.9 (5) 5.0 (8) 
14 Thr 6.7 (12) 7.6 (14) 7.0 (11) 
15 Tyr 2.2 (4) 2.3 (4) 1.3 (2) 
16 Val 10.6 (19) 8.4 (15) 5.7 (9) 
17 Total** 183 (180) 163 (158) 
*The amino acid compositions (expressed in %) were calculated without 
taking into account Cys and Trio residues. 
**Total is the number of amino acid residues in the processed proteins 
while the number of residues used to calculate % is given in parantheses. 
grates as a protein with Mr of 22 kDa (see Fig. 2B). 
bCyP-20 has the highest pI in the cyclophilin family of 
proteins and is flanked on NEPHGE/SDS gels only by 
the high pI ribosomal proteins [12]. bCyP-20 has rela- 
tively strong affinity to cation exchangers including 
DNA and heparin. Both the apo form of bCyP-20 and 
the bCyP-20/CsA complex bind to DNA (see Fig. 3) and 
heparin whereas bCyP-18 does not bind well to cation 
exchangers (data not shown). 
Edman degradation yielded the N-terminal sequence 
NH2-DEKKKGPKVTVKVYFDLRIGDEDIGRVVI- 
GLFGKTVPKTVDNFVAL- which is very similar to 
those of human cyclophilin-S [13], murine cyclophilin-S 
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Fig. 2. (A) NEPHGE/SDS-PAGE of the following proteins: 1, bCyP-20; 2 and 3, two isoforms of bCyP-18; 4, lysozyme; 5, bovine macrophage 
migration inhibitory factor [11]. The positions of molecular mass markers and approximate pI scale are indicated on the sides of the gel; 03) Relative 
migration on a 12% SDS-PAGE gel of bCyP-18 (lane 2) vs. bCyP-20 (lane 3); lane 1, molecular mass markers. 
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Fig. 3. SDS-PAGE gel of bCyP-20 eluted/retained by DNA affinity gels. Lanes 1-6, bCyP-20 eluted from DNA affinity gels with decreasing 
concentration of NaCI; lanes 7-12, bCyP-20 retained by DNA affinity gels treated with increasing concentration f NaCI: 7 (500 mM), 8 (300 raM), 
9 (200 mM), 10 (150 mM), 11 (100 mM), 12 (50 raM); lane 13, the bCyP-20/CsA complex bound to DNA affinity gel; lane 14, CsA binding to the 
preformed bCyP-20/DNA complex. 
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Fig. 4. C~cular dichroism spectra: (A) bCyP-18; (B) bCyP-20. 
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Fig• 5• Alignment of several sequences ofthe cyclophilin family of proteins; the stars indicate the C-terminal amino acid. The sequences come from 
the following sources: (1) hCyP-18, GB:X52851 [20]; (2) hCyP-20, GB:M63573 [21]; (3) mCyP-23, GB:M74227 [22]; (4) hCyP-22, GB:MS0254 [23]; 
(5) hCyP-40, GB:L11667 [24]; (6) hCyP-150, GB:LH04888 [25]. The consecutively numbered secondary structures were taken from the X-ray structure 
of hCyP-18 elucidated by Ke [19]; s--a-helix, t-t-structure, r--~-turn, *-* an extension of the structure. The side chains of hCyP-18 residues (bold 
face) contact CsA [27-28]. 
[14] and chicken cyclophilin-S [15]. There are only two 
conservative substitutions in the N-terminal part of 
bCyP-20 vs. hCyP-20, namely 24V/24I and 281/28V. 
Likewise, the amino acid composition of bCyP-20 is very 
similar to that of hCyP-20, rmsd = 0.8355 (see Table 1). 
In contrast, the amino acid composition of bCyP-18 dif- 
fers significantly from that of bCyP-20 (rmsd = 1 •6263). 
bCyP-20 has PPIase activity which is inhibited by CsA 
at nM concentrations. Circular dichroism spectra of 
bCyP-18 and bCyP-20 show very similar patterns (see 
Fig. 4) which may suggest hat in aqueous olution both 
proteins have nearly identical three-dimensional struc- 
tures. Furthermore, the CD spectra of periplasmic CyP- 
18 from Escherichia coli [16] is similar to those of bCyP- 
18, hCyP-18 and bCyP-20. A recent NMR study on the 
periplasmic CyP-18 from E. coli [17] and the X-ray struc- 
ture of the mCyP-23/CsA complex [18] revealed that 
both proteins have structures very similar to that of 
hCyP-18 [19]. 
Sequence alignment of peptidylproline cis-trans isom- 
erase domains of mammalian cyclophilins indicate for 
remarkable sequence conservancy (see Fig. 5) which 
could result from a universal requirement imopsed on 
this domain to catalyze in vivo protein folding and stabi- 
lize nascent polypeptide chains• The cDNA of hCyP-20 
contains a signal sequence [21] which should translocate 
the protein to the endoplasmic reticulum. The processed 
protein does not possess the signal sequence and begins 
at the amino acid similar to that established by Edman 
degradation for mCyP-20(s) [26]. It is likely however, 
that both due to the high hydrophobicity index of the 
cyclophilin family of proteins, Hi = 36-55 [1], and the 
tendency to bind to weak cation exchangers very basic 
mammalian CyP-20's could be associated with the hy- 
drophobic/polar interfaces of various membranes• 
Moreover, the hCyP-20/CsA complex has even higher 
affinity for calcineurin than the hCyP-18/CsA complex 
itself [4] which may suggest that these complexes can 
effectively compete with each other under in vivo condi- 
tions. Relatively high content of CyP-20 in bovine tissues 
is concomitant with an equally high content of cal- 
cineurin. Since CyP-20 is one of the major components 
of the PPIase family of proteins in the brain, its complex 
with CsA may cause serious neurotoxicity. Morover, 
mammalian CyP-20s may play a variety of functions in 
cellular milieu including its involvement in the signaling 
pathways which comprise both the cytosolic and mem- 
brane-bound calcineurins. 
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